2013 ClinChem Annual Report

1
ANNUAL REPORT
Clinical & Chemical Pathology
Department
Reporting period: January 2013– December 2013
Chair of the Department: Prof. Dr. Mervat El-Ansary
Prepared by: A. Prof. Nelly Abulata
A. Prof. of Clinical Pathology
Edited by: A. Lecturer Cherifa Tarek
A. Lecturer of Clinical Pathology

2
Table of Contents
I. LETTER FROM THE CHAIR…………………………………………………………………….3
II. CLINCHEM AT A GLANCE……………………………………………………………………...5
1. About Us.…………………………………….……………………………………………..…...6
2. Role of the Department………….…………………..…………………………………..………7
III. FACULTY & STAFF….………………………………………………………………………..….8
1. Manpower Overview……………………….……….……………………………………………....9
2. Administrative Roster……………………….……….…………………………………………….10
3. Promotions and Appointments..……………….…………………………………………………..14
IV. TEACHING, TRAINING & EXAMINATION……………….……….……………………….15
1. Teaching & Training…………………………..……………..…………...………………………...16
2. Examination……………………….……….………………………………………………………17
V. RESEARCH & SCIENTIFIC ACTIVITIES…..………………………..….……………..……….18
1. The Department’s Research Plan…………………………..……………..…………...…………….19
2. Research Projects……….……………………….……….…………………………………………19
3. Journal Editorialships/Editorial Reviewers…………………………………….……….…...………19
4. Associations/Societies/Organization/ Committee Memberships……………………….………..…21
5. Publications……………………….……….………………………………………………………..24
6. Training/Courses/ Workshops Activities..………………………………………………………….27
7. Conference Activities...……………………………………………………………………………...28
VI. LABORATORY SERVICES………………………..….............................................................................33
1. Background Information…………………………………..……………………………….………..34
2. Annual Productivity……………………………………………..…………………………………...34
3. Blood Bank Services…………………………………………………..………………………….…..35
4. New tests introduced……………………………….…………………………………….……..……35
5. New techniques introduced……………………………….…………………………………….……36
6. New Lab……………………………………………………………………………………………...36
6. Others………………………………………………………………………………………………..38
VII. COMMUNITY SERVICE………………………………………………………………………....39

4
2013 encompassed many changes in Health Care. Working together with 283 faculty members, nearly 52 residents and several hundred Technologists & Technicians, nurses, administrators, and staff who make up the department, we have made rapid strides toward achieving those goals. This year we achieved an overall annual productivity of 5,521,930 tests, which could not have been reached, without our dedicated manpower (1,215 employees). With the appointment of new Heads of Laboratories, Heads of Units and Laboratory Directors and with the creation of an Executive Committee, the Department now has the infrastructure it needs to continue its path.
All through 2013, we continued a steady expansion in our three major missions; Laboratory Services, Teaching & Training and Research Activities. In the Laboratory service arena, we continued to push ahead with the implementation of Quality Assurance System at our Lab Branches. The New ER Lab at the New ER Hospital has opened and in addition to a new ER Blood Bank. The Japenese Lab underwent major changes and developments in its infrastructure & we expect it to further blossom in 2014.
Teaching & Training activities also remained very strong. Our goal is to train Clinical & Chemical Pathologists who will make a difference whether they chose a career path in academic medicine or in clinical practice. In addition to the pre– Master & pre-Doctorate teaching & training programs we now offer regular training to the Egyptian Fellowship Board Students in addition to 2 weeks condensed summer training program to undergraduate students. We continued the partnership we formed last year with the Training Program in Regenerative Medicine (TPRM) of the University of Toronto in Canadawhich introduced Regenerative Medicine in Cairo University. TPRM offered regular weekly lectures from September 2013 to April 2014 that will be webcasted from Toronto and were displayed at an auditorium in the Learning Resource Center (LRC) in Kasr Al-Ainy. This was the a first building block for the Regenerative Medicine Unit that was inaugurated in 2013 that will hopefully start running by mid 2014.
In the Research arena, several research projects were funded by the faculty under the roof of the 2- 5yr plan for the Research activities of the Department, which involved all 4 specialties of the Department (Hematology, Immunology, Microbiology and Chemistry. As for our Faculty publications, over 50 articles were published in international Journals, several of which were in the high impact journals. Our yearly ClinChem Conference legacy was held in April 2013 under the title Is Regenerative Medicine a hope or hype? That was held at the Learning Resource Center at Kasr Al- Ainy Faculty of Medicine. Another source of pride was the work of our Faculty Staff in a collaborative initiative with the Egyptian Society of Laboratory Medicine in organizing ESLM 2013 Conference, which was held at the Cairo International Conference Center in April 2013.
In summary, the Department remains strong and undergoing carefully planned incremental growth, reflecting both our role in academia and in Laboratory service. With the opening of the the new Labs and units we look forward to gradual recruitment of several more staff and also to working closely with all of our other colleagues in the Faculty and Hospital to build our research, teaching and clinical enterprise in a fashion that melds with programmatic directions of the University as a whole.
Prof. Dr. Mervat El-Ansary
Chair, Clinical and Chemical Pathology Department

5
II- CLINCHEM DEPARTMENT AT A GLANCE:

6
1- ABOUT US
a. Mission
“Is to provide excellence in Laboratory services, Teaching, Training and Research activities”.
b. Vision
We aspire to be recognized as an Academic Department of excellence to support and enhance the mission and vision of Kasr Al-Ainy Faculty of Medicine, Cairo University.
c. Objectives
1. To provide excellent laboratory medicine services for the patients of Kasr Al-Ainy Hospital in a timely & professional manner.
2. To provide an atmosphere of respect for our staff while encouraging continued personal growth, education and development.
3. To provide excellent teaching to a broad spectrum of health care professionals, health care workers and Lab personnel in conjunction with The University.
4. To provide the physical facilities and atmosphere where research activities can flourish, in collaboration with Kasr Al-Ainy Faculty of Medicine and other affiliated institutions.
5. To promote health, treatment and prevention of disease in the diverse population which we serve.

7
2- ROLE OF THE DEPARTMENT
a. Teaching & Training:
The Department is committed to providing strong and balanced Teaching and Training programs mainly to Postgraduate Students, principally in the Master and Doctorate degrees in Clinical and Chemical Pathology tailored to each student subspecialty (Hematology, Immunology, Microbiology or Chemical Pathology). The Department is also partly involved in the Teaching & Training of Postgraduate Students of other Departments enrolled in Doctorate, Master & Diplomas degrees in addition it provides instructional courses to the 6th year students. And for the last 2 summers it offered a condensed 2 weeks training course to undergraduate students.
b. Research Activities:
The Research Faculty members within the Department are nationally recognized. The Research ranges from clinical to basic Research, with an emphasis on Hematologic Malignancies, Virology & Molecular Genetics.
c. Laboratory Services:
The Department offers Clinical and Chemical Laboratory services designed to meet the needs of physicians, & patients. The Department has 2 Main Labs at Al-Manial Hospital, a Lab. in each of the following Hospitals; the Specialized Hospital (4th Floor), the Internal Medicine Hospital, the Pediatric Japanese Hospital, the Pediatric Abou Elrish Hospital, King Fahd Hospital, the French Hospital, the new Lab at the Maternity Hospital, in addition to Emergency Labs that offer the Lab services during the evening and night shifts. The Department is also responsible for the Technical supervision of the Blood Bank and recently has recently become responsible for the Lab at the Clinical Oncology and Nuclear Medicine Department.
Laboratory
Services
Research
Teaching &
Training

9
1- OVERVIEW OF MAN POWER
The Department has a total manpower of 1215 employees. This comprises:
 369 Doctors; 283 Faculty members, 34 Specialists & 52 Residents
 372 Technologists & Technicians
 60 Nurses
 199 Administration
 65 Cleaners
283
34
52
Doctors
Faculty Staff
Specialists
Residents
369
372
60
199
65
0
50
100
150
200
250
300
350
400
Doctors
Technologists &
Technicians
Nurses
Adminstration
Cleaners
Human Resources

10
2. ADMINISTRATIVE ROSTERS:
a. Chair of the Department: Prof. Dr. Mervat El-Ansary
b. Deputies:
i. Deputy for Examination, Staff Positioning/ Relocation Affairs: Prof. Dr. Hanaa Arnaout
ii. Deputy for Teaching, Training Affairs: Prof. Dr. Hala Farawela
iii. Deputy for Scientific Research Development Affairs: Prof. Dr. Hala Gabr.
c. Seniors of each Division:
i. Senior Hematologist: Prof. Dr. Hanaa Arnaout
ii. Senior Immunologist: Prof. Dr. Inas Rafaat
iii. Senior Microbiologist: Prof. Dr. Amani El Kholy
iv. Senior Chemical Pathologist: Prof. Dr. Fatma El Mougy
d. Advisors to the Chair of the Clinical & Chemical Pathology Department:
i. Hematology Advisor: Prof. Dr. Azza Mostafa
ii. Immunology Advisor: Prof. Dr. Safaa Al-Karaksy
iii. Microbiology Advisor: Prof. Dr. Soheir Helal
iv. Chemical Pathology Advisor: Prof. Dr. Sara AlKatib
e. Secretary General of the Council of the ClinChem Department: Dr. Nelly Abulata
Chair of the Clinical & Chemical Pathology Dept
Deputy for Examination & Positioning/ Relocation Affairs
Team with representatives of all specialties
Deputy for Teaching, Training Staff Affairs
Deputy for Scientific Research Affairs

11
f. Technical Development Officer: Dr. Nelly Abulata
g. Committees (2012-2013)
i. Executive Committee for Laboratory Services:
 Head of the Committee: Prof. Dr. Mervat El-Ansary
 Moderator of the Committee: Dr. Nelly Abulata
 Members of the Committee:
Main Lab at Manial Hospital
Lab Head of Lab. (Technical) Lab Director (Administrative) Head of Hematology Unit Head of Immunology Unit Head of Genetics unit Head of the Molecular Unit Head of Microbiology Unit Manial Clinical Pathology Lab. Prof. Dr. Hala Sheebah Dr. Hanan A. Moneim Prof. Dr. Hala Sheebah Prof. Dr. Noha Shaheen Prof. Dr. Hala Farawela Prof. Dr. Mona Salah Prof. Dr. Mona Wassef
Lab Head of Lab. (Technical) Lab Director (Administrative) Head of Trace Elements Unit Head of Chemistry Routine Unit Head of Proteins Unit Head of Hormones Unit Manial Chemical Pathology Lab. Prof. Dr. Fatma El- Mougy Prof. Dr. Badawy Al-Khouly Prof. Dr. Badawy Al- Khouly Prof. Dr. Lamia Mansour Prof. Dr. Sahar Abdel-Atty Prof. Dr. Nadida Gohar

12
Other Hospital based labs
Laboratory Head of Lab. (Technical) Lab Director (Administrative) Head of Hematology Head of Immunology Head of Microbiology Head of Chemical Pathology Internal Medicine Hospital Lab. Prof. Dr. Sahar Kamal Prof. Dr. Sahar Kamal Prof. Dr. Sahar Kamal Prof. Dr. Nancy El- Guindy A. Prof. Dr. Amaal Abdou Japanese Hospital Lab. Prof. Dr. Hanaa Arnaout Prof. Dr. Iman Mansour Prof. Dr. Hanaa Arnaout A. Prof. Dr. Reem Jan Prof. Dr. Mona Mohie El-Din Prof. Dr. Amal AbdelWahab Abou-Elrish Mounira Hospital Lab. Prof. Dr. Azza Abou El-Enian Prof. Nesrine ElGharbawi Prof. Dr. Hala Gabr Prof. Hend ElSherbiny Prof. Dr. Maha Gaafar Prof. Dr. Heba Sharaf El-Din Specialized Hospital Lab. (4th floor) Prof. Dr. Taysir Eyada Prof. Dr. Hoda Sadek A. Prof. Dr. Dina Rasheed Prof. Dr. Mervat Gabr Prof. Dr. Amed ElTawil French Hospital Lab. Prof. Dr. Laila Hegazy Dr. Hanan Ibrahim Prof. Dr. Naguib Zoheir Prof. Dr. Nancy El- Guindy Prof. Dr. Neven ElRasheedy Prof. Dr. Ola ElSissi King Fahd Hospital Lab. A. Prof. Dr. Manal Kamal Psychiatric Hospital Lab. Prof. Dr. Badawy Al-Khouly New ER Hospital Lab Prof. Dr. Badawy Al-Khouly Maternity Hospital Lab. Prof. Dr. Iman Mandour Prof. Dr. Hanan Nour Sharm ElSheikh Int. Hosp. Assistant Prof. Mohamed Shehata Blood Bank Prof. Dr. Mervat Al- Ansary Dr. Sahar Azab
Unit Closed and work is referred to the main lab or nearest specialized lab

13
i. Executive Committee for Blood Bank Affairs:
 Director General of Hospitals: Prof. Dr. Alaa Maher
 Deputy Director General of Hospitals: Prof. Dr. Ahmed Taha
 Director of ER Hospital: Prof. Dr. Hesham Abou Eisha
 Director of OR: Prof. Dr. Mohamed Hassan
 Deputy Director of ER Hospital for Critical Care: Prof. Dr.Hesham Khedr
 Chair of the Department & Head of the Blood Bank: Prof. Dr. Mervat Al-Ansary
 Moderator: Prof. Dr. Ossama Khalafalla
 Blood Bank Director: Dr. Sahar Azab
ii. Ethical Committee for Scientific Research:
 Head of the Committee: Prof. Dr. Azza Mostafa
 Hematology: Prof. Dr. Hanaa Arnaout, Prof. Dr. Samia Rizk
 Immunology: Prof. Prof. Dr. Tagrid Gafar, Dr. Mervat El-Ansary.
 Chemical Pathology: Prof. Dr. Fatma El-Mougy, Prof. Dr. Hazem Abou Youssef
 Microbiology: Prof. Dr. Amani El-Kholy, Prof. Dr. Mona Wassef
iii. Quality Assurance Committee for Laboratory Service
 Project Leader: Consultant Dr. Ola Khashaba.
 Team Members: The Heads of the Hematology, Immunology, Microbiology and Chemical Pathology Department have nominated members of the teams.
iv. Quality Assurance Committee for Education
 Leader Prof. Dr. Shereen Mahmoud
 Team Members: The Heads of the Hematology, Immunology, Microbiology and Chemical Pathology Department have nominated members of the teams.

14
3. Promotions and Appointments
a. Promotions
Promoted to Professor
Promoted to Assistant Professor
Promoted to Lecturer
Promoted to Assistant Lecturer
i. A. Prof. Dina ElAbd
ii. A. Prof. Noha Shaheen
iii. A. Prof. Doha AbdelHamid
iv. A. Prof. Marianne Fathy
v. A. Prof. Aya Nassef
i. Dr. Reham Zeyada
ii. Dr. Nadia Sewelam
iii. Dr. Shahira Anis
iv. Dr. Nevine Bahaa
v. Dr. Nelly Abulata
i. Dr. Ahmed Abdelhafez
ii. Dr. Reem Mostafa
iii. Dr. Mai Sherief
iv. Dr. Rehab ElHusseiny
v. Dr. Alaa Afifi
i. Dr. Noha Salah Eldin
ii. Dr. Mona Hazem
iii. Dr. Amira Farouk
iv. Dr. Radwa Marawan
v. Dr. Mahitab AbdelKawy
vi. Dr. Lamis Samy
vii. Dr. Salwa Khedr
viii. Dr. Nouran Momen
ix. Dr. Maysa Ibrahim
x. Dr. Heba AbdelRahman
xi. Dr. Sherifa Tarek
xii. Dr. Rania Essam
xiii. Dr. Heba Adel
xiv. Dr. Nashwa Reda
xv. Dr. Dina Ezzat
xvi. Dr. Alia ElDash
b. Appointments as Demonstrators:
 Dr. Reem Khalid
 Dr. Ragda Taha
 Dr. Heba ElGohary
 Dr. Lamia Hany
 Dr. Hend Tameem
 Dr. Menatallah Mohamed
 Dr. Aisha Omar
 Dr. Amira Kotb
 Dr. Zainab Sayed
 Dr. Amal Bahgat
 Dr. Amira ElSayed
 Dr. Mariam Baligh
 Dr. Shaima Mahmoud
 Dr. Alaa Mohamed

15
IV. TEACHING, TRAINING & EXAMINATION

16
1. Teaching & Training
a. Undergraduates
 Clinical & Chemical Pathology curriculum teaching to the 6th year Students
 Summer Training Programs to Undergraduate Students
b. Postgraduate
 Clinical and Chemical Pathology Degrees
 Master Degree of Clinical & Chemical Pathology- First Part (Hematology)
 Master Degree of Clinical & Chemical Pathology- First Part (Immunology)
 Master Degree of Clinical & Chemical Pathology- First Part (Microbiology)
 Master Degree of Clinical & Chemical Pathology- First Part (Chemical Pathology)
 Master Degree of Clinical & Chemical Pathology- Second Part (Hematology)
 Master Degree of Clinical & Chemical Pathology- Second Part (Immunology)
 Master Degree of Clinical & Chemical Pathology- Second Part (Microbiology)
 Master Degree of Clinical & Chemical Pathology- Second Part
(Chemical Pathology)
 Of other Specialities
 Master Degree of Clinical Hematology
 Master Degree of E.N.T
 Master Degree of Internal Medicine
 Master Degree of Physiology
 Doctorate Degree of Clinical & Chemical Pathology (Hematology)
 Doctorate Degree of Clinical & Chemical Pathology (Immunology)
 Doctorate Degree of Clinical & Chemical Pathology (Microbiology)
 Doctorate Degree of Clinical & Chemical Pathology (Chemical Pathology)
 Doctorate Degree of Andrology
 Doctorate Degree of Pediatrics
 Doctorate Degree of Critical Care
 Doctorate Degree of Clinical Hematology
c. Others
 Weekly Seminars
o Immunology: Every Sunday of the week
o Hematology: Every Monday of the week
o Chemical Pathology: Every Monday of the week
o Microbiology: Every Tuesday of the week
 Egyptian Fellowship Board Training Program
 House Officers Training Program
 Faculty of Nursing Teaching & Training Program
 Nursing School Teaching & Training Program

17
2. Examinations (Written, Oral, Practical)
a. Undergraduates
 6th year Clinical & Chemical Pathology exam
b. Postgraduate
 Clinical and Chemical Pathology Degrees
 Master Degree of Clinical & Chemical Pathology- First Part (Hematology)
 Master Degree of Clinical & Chemical Pathology- First Part (Immunology)
 Master Degree of Clinical & Chemical Pathology- First Part (Microbiology)
 Master Degree of Clinical & Chemical Pathology- First Part (Chemical Pathology)
 Master Degree of Clinical & Chemical Pathology- Second Part (Hematology)
 Master Degree of Clinical & Chemical Pathology- Second Part (Immunology)
 Master Degree of Clinical & Chemical Pathology- Second Part (Microbiology)
 Master Degree of Clinical & Chemical Pathology- Second Part
(Chemical Pathology)
 Of other Specialties
 Master Degree of Clinical Hematology
 Master Degree of E.N.T
 Master Degree of Internal Medicine
 Master Degree of Physiology
 Doctorate Degree of Clinical & Chemical Pathology (Hematology)
 Doctorate Degree of Clinical & Chemical Pathology (Immunology)
 Doctorate Degree of Clinical & Chemical Pathology (Microbiology)
 Doctorate Degree of Clinical & Chemical Pathology (Chemical Pathology)
 Doctorate Degree of Andrology
 Doctorate Degree of Pediatrics
 Doctorate Degree of Critical Care
 Doctorate Degree of Clinical Hematology
c. Others
 Faculty of Nursing Teaching & Training Program
 Nursing School Teaching & Training Program

18
V. RESEARCH & SCIENTIFIC ACTIVITIES

19
1. The Department’s Research Plan
a. Project Profile: The aim of this project is to develop a plan for the Research activities of the Department over the coming 2-5 yrs (2009- 2013), which will involve all the specialties of the Department. The project will hopefully lead to the international recognition of the Department that will in turn participate in the International recognition of Kasr Al-Ainy Faculty of Medicine.
b. Project starting date: 27/08/09
c. Project structure:
i. Project Leader: Prof. Dr. Ali Shams El-Din
ii. Research Officer: Prof. Dr. Hala Gabr
iii. Project Team Members: Prof. Azza Mostafa, Prof. Taghrid Gaafar, Prof. Amani El-Kholy, Prof. Fatma El-Mougy, Prof. Mona Wasif, Prof. Hala Farawela, Prof. Afaf ElBannah, Prof. Iman Mansour, Prof. Hala Ali, Prof. Hala Gabr, Prof. Sahar Abdel Atty
d. Key research subjects
i. HCV
ii. Stem Cell Research
iii. Neurodegenerative diseases
iv. Infection prevention and control
v. Molecular basis of Hematological disorders
vi. Juvenile Diabetes Mellitus.
2. Research Projects
Ministry of Higher Education funded by the Project Management Unit: Improving the performance of microbiology laboratory and its preparation for accreditation by ISO15189. Budget is 530 000 LE (Investigator: Prof. Dr. Amani ElKholy)
STDF Basic & Applied Research Grants in the framework of the German-Egyptian Research Fund (GERF 2010): Strategies to improve early engraftment of transplanted cardiomyocytes. (Principal investigator: Prof. Dr. Heba Abdel-Razik, Co-investigators: Prof. Dr. Doha Abdel- Hamid Mokhtar &A. Prof. Rania Ahmed Zayed).
STDF projects:
1. Rapid molecular diagnosis of congenital Adrenal Hyperplasia by Strip hybridization assay.
2. The Pathogenesis of Hepatitis C Virus Vertical Transmission
(Projects PI: Prof. Dr. Fatma Ahmed F. El Mougy)

20
3. Journal Editorialships /Editorial Reviewers
a. Editorialships
i. Editor in Chief
 Egyptian Journal Of Laboratory Medicine (Prof. Dr. Ali Shams ElDin)
ii. Managing Editor
 Egyptian Journal Of Laboratory Medicine (Prof. Dr. Naguib Zohair)
iii. Assistant Editors
 Egyptian Journal Of Laboratory Medicine
o Prof. Sahar Abdel Atty
o A. Prof. Mervat Khorshied
o A. Prof. Heba Gouda
b. Reviewers
i. The Egyptian Journal of Hematology Prof. Dr. Azza Mostafa
ii. The Egyptian Journal of Hematology & Research (Prof. Dr. Azza Mostafa)
iii. Reviewer of STDF Projects
 Prof. Dr. Azza Mostafa
 Prof. Dr. Samia Rizk
iv. The Cairo University Medical Journal (Prof. Dr. Azza Mostafa)
v. Journal of Egyptian Heart Journal (Prof. Dr. Amani El Kholy)
vi. Journal of Laboratory Medicine
 Prof. Dr. Amani El Kholy
vii. Journal of Advanced Research
 Prof. Amani ElKholy
 Prof. Hala Ali
 Prof. Iman Mandour
viii. Journal of Egyptian National Cancer Institute
 Prof. Hala Ali
ix. Arab Journal of Gastroenterology (Dr. Nelly Abulata)
x. IJMMS (Prof. Fayza Hassan)
xi. Journal of Inherited Metabolic Disease (Prof. Dr. Fayza Hassan)
xii. Journal of Infection in developing countries, South African journal of infectious diseases (Prof. Dr. Amani El Kholy)
xiii. Journal of Leukemia Research (A. Prof. Dr. Mervat Khorshied)
xiv. Journal of Targeted Oncology
 A. Prof. Dr.Mervat Khorshied
 A.Prof. Dr. Heba Gouda
xv. Journal of Blood, Coagulation & Fibrinolysis (A. Prof. Dr. Heba Gouda)
xvi. Journal of Medicine and Biomedical Sciences (Prof. Dr. Eiman AbdulRahman)
xvii. Journal of Medicine and Medical Sciences (A. Prof. Dr. Rania Zayed)
xviii. International Journal of Medicine and Medical Sciences (A. Prof. Dr. Rania Zayed)
xix. Nutrition, Metabolism and cardiovascular Diseases Journal (A. Prof. Dr. Rania

21
Zayed)
xx. Journal of Pregnancy Hypertension (A. Prof. Dr. Asmaa Abd El-Aal)
xxi. Journal of Gene Therapy and Molecular Biology
 A. Prof. Dr. Manal Makhlouf
 A. Prof. Nelly Abulata
xxii. Journal of Cancer Research and Clinical Oncology (A. Prof. Dr. Manal Makhlouf)
xxiii. Comparative Clinical Pathology Journal
 Prof. Dr. Sahar Abdel Atty
 Prof. Dr. Iman Mandour
 A. Prof. Dr. Marianne Samir
 A. Prof. Dr. Mervat Khorshied
 A. Prof. Dr. Heba Gouda
 A. Prof. Dr. Rania Zayed
 A. Prof. Dr. Asmaa Abd El-Aal
 A. Prof. Dr. Hanan Madani
 Dr. Mona Fathy
 Dr. Nahed Mohamed
xxiv. Clinical Biochemistry (A. Prof. Dr. Somia Moussa)
xxv. Indian Journal of Medical Microbiology (A. Prof. Dr. Maha Gaafar)
xxvi. Lab Medicine (A. Prof. Dr. Somia Moussa)
xxvii. Journal of Cancer Science & Therapy (A. Prof. Dr. Somia Moussa)
xxviii. Molecular Diagnosis & Therapy Journal (A.Prof. Marianne Samir)
xxix. European Journal of Drug Metabolism and Pharmacokinetics (A.Prof. Marianne Samir)
xxx. Journal of Clinical Laboratory Analysis (A.Prof. Marianne Samir)
xxxi. PLOS One Journals (A.Prof. Marianne Samir)
xxxii. Journal of the Egyptian Cancer Institute (Prof. Amani ElKholy)
xxxiii. Ibnosina Journal of Medicine and Biomedical Sciences (Prof. Eiman M.AbdulRahman)
xxxiv. The Indian Journal of Medical Microbiology (Prof. Iman Behiry)
xxxv. International Journals of microbiology research and reviews (Prof. Mona Mohie ElDin)
xxxvi. European Scientific Journal (A. Prof. Rania Zayed)
xxxvii. International Journal of Medicine and Medical Sciences (A. Prof. Rania Zayed)
xxxviii. Journal of Pediatric Infectious Diseases (A. Prof. Rania Zayed)
xxxix. Journal of DNA and Cell Biology (A. Prof. Rania Zayed)
4. Associations/Societies/ Organizations/ Committee Memberships
a. Membership in Associations/ Societies
i. International Society for Neonatal Screening (Prof. Dr. Fayza Hassan)

22
ii. American Association of Clinical Chemistry
 Prof. Dr. Nadida Gohar
 Dr. Riham ElSayed
iii. European Society of immunodeficiency (Dr. Safa Sayed Meshal)
iv. Egyptian Association of Clinical Chemistry (Prof. Dr. Fayza Hassan)
v. Arab Society for Infectious Diseases and Antimicrobial Chemotherapy (ASIDA) (Prof. Dr. Amani El Kholy)
vi. Egyptian Society for Infection Control (Prof. Dr. Amani El Kholy)
vii. Society of Practitioners of Infection control in Egypt: Board member Prof. Dr. Amani El Kholy)
viii. Egyptian hematology group (EHOG) (Prof. Dr. Amani El Kholy)
ix. Egyptian Patient Safety Association (EPSA) (Prof. Dr. Amani El Kholy)
x. American Society for Microbiology (Prof. Dr. Amani El Kholy)
xi. International Federation for Infection Control (Prof. Amani El Kholy, Prof. Dr. Mona Mohie Eldin)
xii. Society of Healthcare Epidemiology of America (Prof. Dr. Amani El Kholy)
xiii. Society of Clinical Research Associates (Prof. Dr. Samia Rizk)
xiv. European Bone Marrow Phathology working group”, an affiliate of the European Association for Hematopathology (Prof. Dr. Samia Rizk)
xv. American Society of Clinical Pathology (Prof. Dr. Samia Rizk)
xvi. European Association of Hematopathology (Prof. Dr. Samia Rizk)
xvii. Thalassemia International Federation (Prof. Dr. Samia Rizk)
xviii. MAREP- SPIC- Egypt (Prof. Mona Mohie Eldin)
xix. The Egyptian Society of Laboratory Medicine
 Prof. Mervat El Ansary
 Prof. Fayza Hassan
 Prof. Dr. Taghrid Gaafar
 Prof. Dr. Nadida Gohar
 Prof. Dr. Hoda Abdel Ghany
 Prof. Dr. Hala Ali
 Prof. Dr. Marianne Morgan
 Prof. Dr. Doha Mokhtar
 A. Prof. Manal Kamal
 A. Prof. Dr. Maha Gaafar
 A. Prof. Dr. Mona Mohie Eldin
 A. Prof. Dr. Nohair Soliman
 A. Prof. Hanan Madani
 Dr. Nadia Sewelam
 Dr. Nelly Abulata
xx. Egyptian Society of Hematology
 Prof. Dr. Mervat El Ansary

23
xxi. Egyptian Society of Hematology & Research
 Prof. Dr. Hoda Abdel Ghany
 Prof. Dr. Hala Ali
xxii. Society of Nephrology (Prof. Dr. Mervat El Ansary)
xxiii. Society of Stem cell (Prof. Dr. Mervat El Ansary)
xxiv. Society of AABB (Prof. Dr. Mervat El Ansary)
xxv. The Egypt Society of Hepatology, GIT & Infectious Disease (Prof. Dr. Mervat El Ansary)
xxvi. Egyptian Inherited metabolic disorder friends association (Dr. Mohamed Abdel Monem)
xxvii. Egyptian group for Orphan renal diseases (EGORD) (Dr. Mohamed Abdel Monem)
xxviii. Society of Haematology and Transfusion Medicine (Prof. Dr. Mervat El Ansary)
xxix. Egyptian Society for progenitor cell research (Prof. Dr. Mervat El Ansary)
xxx. Egyptian Society of Liver Cancer (Prof. Dr. Mervat El Ansary)
xxxi. Metabolic diseases patients friends association (Prof. Dr. Marianne Morgan)
xxxii. Scientific Society of inborn errors of metabolism (Prof. Dr. Sahar Abdel Atty)
xxxiii. Association for Women’s Total and Advanced Development (AWTAD) – (Dr. Nelly Abulata)
xxxiv. American Society for Microbiology (Prof. Dr. Amani El Kholy)
xxxv. International Nosocomial Infection Control Consortium (Prof. Dr. Amani El Kholy)
xxxvi. International Society for Cardiovascular Infections (Prof. Dr. Amani El Kholy)
xxxvii. Arab Society of Infectious Diseases and Antimicrobials (Dr. Dina Hassan)
xxxviii. American society of Laboratory Medicine (Dr. Dina Hassan)
xxxix. The Doctors French Egyptian Scientific Society (Prof. Iman Behiry)
b. Memberships in Organizations
i. Public responsibility in medicine and research (PRIM&R) organization (Prof. Dr. Samia Rizk)
ii. Technical advisory panel in: The Joint Commission. Preventing Central Line–Associated. Bloodstream Infections: A Global Challenge, a Global Perspective. Oak Brook, IL: Joint Commission Resources, (Prof. Dr. Amani El Kholy)

24
iii. Kasr ElAini Friends’Association (KEFA)
 Prof. Dr. Iman Mandour
 Prof. Dr. Marianne Morgan
 Dr. Mohamed Abdel Moneim
c. Memberships of Committees i. National hepatitis C control committee at Ministry of health(Prof. Dr. Iman Behiry) ii. Higher Committee for Infection Prevention and Control, Cairo University Hospitals (Prof. Dr. Amani El Kholy) iii. Higher Education Promotion Committee for Assistant Professors and Professors (Prof. Dr. Amani El Kholy) iv. Infection Control Committee for university hospitals, Supreme Council for Universities, Ministry of Higher Education (Prof. Dr. Amani El Kholy) v. National Task Force Committeee for Infection Prevention and Control (Prof. Dr. Amani El Kholy) vi. National Task Force Committeee for Prevention of hepatitis and Injection safety (Prof. Dr. Amani El Kholy) vii. Higher Committee for Infection Prevention and Control in Cairo University Hospital (Prof. Dr. Amani El Kholy) viii. Cairo University Specialized Paediatric Hospital Committee ( CUSPH) (Prof. Dr. Mona Mohie ElDin)
5. Publications
 A disintegrin and metalloproteinase 33 (ADAM33) gene polymorphism association with asthma in Egyptian children. Mona M. El-Falaki, Manal M. Wilson, Ghada M. Ezzat, Doha A. Mokhtar, Mohamed S. El Baz, Dina H. Hamed. Egyptian Journal of Medical Human Genetics, Volume 14, Isue 1, January 2013.
 A Novel Mutation of the Ornithine Transcarbamylase Gene Leading to Fatal Hyperammonemia in a Liver Transplant Recipient. Mukhtar, H. Dabbous, R. El Sayed, F. Aboulfetouh, M. Bahaa, A. Abdelaal, M. Fathy, M. El-Meteini: Am J Transplant; 13(4): 1084-7 (2013).
 A systematic clinical comparison Elmonem MA, Ramadan DI, Issac MSM, Selim LA, Elkateb SM. Blood spot versus plasma chitotriosidase, Accepted for publication (20th October 2013) at Clinical Biochemistry.
 Adrenomedullin concentrations in acute asthmatic children, Mohammed Abdel Motey, Mohamed Baz, Nelly Abulata & Shaima Salah, Journal of Arab Child, January 2013.
 Assessment of respiratory involvement in children with mucoplysaccharidosis using pulmonary function tests, El Falaki MM, Girgis MY, Ali AA, Elmonem MA, Ismail HM Accepted for publication (14th October 2013) at Egyptian journal of medical human genetics.
 Association of E-Selectin Gene Polymorphism and Serum PAPP-A with Carotid Atherosclerosis in End-Stage Renal Disease. Marianne Samir M. Issac, Alaa Afif, Nadida A. Gohar, Nahla A. Fawzy Fayek , Bahaa Zayed , Heba Sedrak , Lamiaa Adel Salah El Din. Mol Diagn Ther. Epub 23 October 2013.

25
 B- Cell Activating Factor Promoter Polymorphisms in Egyptian Patients with Systemic Lupus Erythematosus. Rania A. Zayed, Hala F. Sheba, Mennat Allah K. Abo Elazaem, Zainab A. Elsaadany, Lobna O. Elmessery, Jelan A. Mahmoud, Dalia R. Abdel Rahman and Faten R. Abdou. Annals of Clinical & Laboratory Science, vol. 43, no. 3, 2013.
 Biotyping and Molecular Characterization of Klebsiella pneumoniae Producing Extended-Spectrum Beta-Lactamase in Cairo, Egypt: A Multicentre Study. Aisha Abu Aitta1, Manal El Said, Doaa Gamal, Amani El-Kholy, Momtaz Omer, Mohmoud Kamel, Hesham Mohamed. Researcher 2013; 5 (9).
 Blood Spot versus Plasma Chitotriosidase: A Systematic Clinical Comparison. Mohamed A Elmonem, Dalia I Ramadan, Marianne S. M. Issac, Laila A Selim, Sara M Elkateb. Clinical Biochemistry Epub 24 October 2013.
 CD4+ CD25+ cells in type1 diabetic patients with other autoimmune manifestations Abd Elaziz D., Hafez M.; Galal N., Meshaal S., Aisha El Marsafy A. (2013). "". JAR; accepted on September 2013.
 Chromogenic Cica-β Testing for Detection of Extended-Spectrum and AmpC β- Lactamases Among Cefoxitin-Resistant Isolates. Mona A. Wassef and Eiman Mohammed Abdul Rahman. Lab Medicine. Feb 2013, 44, 1:18-21.
 Comparative characteristics of endothelial like cells derived from human adipose mesenchymal stem cells and umbilical cord blood-derived endothelial cells. Taghrid M. Gaafar, Hala A. Abdel Rahman, Wael Attia, Hala S. Hamza, Konrad Brockmeier & Rabab E. El Hawary. Clin Exp Med.
 Comparison between Different Cord Blood Stem Cell Populations in Efficiency of Transdifferentiation into Hepatic Lineage. Hala Gabr, Rania Zayed, Ahmed Rezk Elzayat. ESJ June 2013/special/edition/No.3.
 CYP 17 and Estrogen Receptor α Gene Polymorphisms: Association with Breast Cancer Susceptibility and Clinico-pathological Parameters in a cohort of Egyptian Patients. Nadida Gohar, Dina El Gayar, Marianne Samir M. Issac, Mohammed Shehata, Yasmine Khater, Ezzat Safwat. Comp Clin Pathol Epub 14 November 2013.
 Cytotoxic T lymphocyte antigen 4 gene polymorphism in Systemic Lupus Erythematosus Egyptian patients; Nancy El Guindy, Heba A. AbdEl Ghaffar, Rasha El Refai, Rabab E. El Hawary, Comparative clinical pathology; Comparative clinical pathology.
 Detection of trisomy 4 and 10 in Egyptian pediatric patients with acute lymphoblastic leukemia. Somaia Mousa, Shady Mostafa, Iman Shahin, Esam Elnoshokaty. Clinical Laboratory. 2013.130308.
 Dihydrorhodamine Flow cytometric test in Egyptian patients with symptoms suggestive of Chronic Granulomatous Disease. Meshaal S., Elhawary R., Alkady R., Abdel Aziz D., Galal N., Boutros J, El Marsafy A. Eg J Lab Med. Accepted on April 2013.
 Do MDR1 and SLCO1B1 Polymorphisms Influence the Therapeutic Response to Atorvastatin? A Study on a Cohort of Egyptian Patients with Hypercholesterolemia. Mona F. Shabana, Amal A. Mishriki, Marianne Samir M. Issac & Sameh W. G. Bakhoum. Mol Diagn Ther. 2013; 17: 299–309.
 Enhancing ex vivo Expansion of cord blood-derived Unrestricted Somatic Stem Cells for Clinical Applications. Z.D, emerdash, H. EL Baz, F. Mahmoud, S. Mahmoud,K. Maher,T. Gaafar, S. Shawky, M. Hassan,D. Abdelhady ,and T. Taha. Cell proliferationJournal, 2013;46:628-636

26
 Frequency of human hemochromatosis (HFE) gene mutations in Egyptians with b- thalassemia. Doha A. Mokhtar, Mona M. Hamdy and Ahmed M. Badr. Egyptian Journal of Haematology 2013, Vol 38, No 1.
 Incidence and pathogen distribution of healthcare-associated infections in pilot hospitals in Egypt. See I, Lessa FC, ElAta OA, Hafez S, Samy K, El-Kholy A, El Anani MG, Ismail G, Kandeel A, Galal R, Ellingson K, Talaat M. Infect Control Hosp Epidemiol. 2013 Dec; 34(12):1281-8. doi: 10.1086/673985. Epub 2013 Oct 30.
 Influence of transforming growth factor-b1 gene polymorphism on clearance of hepatitis c virus and development of hepatic fibrosis among egyption patients with chronic hcv infection. Ela. Mervat, A.N.Aya, Abdel H. Hanan, Abdel H. Hanan and Abd Fl f. Walaa. The Arab Journal of Laboratory Medicine May 2013 Vol. 39, No. 2: 427 – 435.  Is There a Role for MDR1, EPHX1 and Protein Z Gene Variants in Modulation of Warfarin Dosage? A Study on a Cohort of the Egyptian Population. Marianne Samir M. Issac, Maggie S. El-Nahid, Marian Youssry Wissa. Mol Diagn Ther. Epub 3 October 2013.
 Mannose-binding lectin exon 1 polymorphisms in Egyptian patients with chronic hepatitis C virus infection. Amaal Abdelaal & Nehad Mossad & Hanan Abdel Hafez & Naglaa Elsayed. Comp Clin Pathol Vol 22 No 4 July 2013
 Mesenchymal stem cell separation from Wharton’s jelly and its differentiation into keratinocytes, Irene Ellia M. Bishai, Mervat Saad El Ansary, Noha M. Hosny Shaheen, Reem Jan Farid. Journal of Comp Clin Pathol (2013).
 Mutational spectrum of CTNS gene in Egyptian patients with nephropathic cystinosis, Soliman NA, Elmonem MA, van den Heuvel L, Abdelhamid RH, Gamal M, Bongaers I, Marie S, Levtchenko E. Accepted for publication (5th December 2013) at Journal of Inherited Metabolic Disease reports.
 P2Y12 Receptor Gene Polymorphism and Anti-platelet effect of Clopidogrel in patients with Coronary artery disease after Coronary stenting, Naguib Zoheir, Samah Saleh, Nelly Abulata, Doaa Khafagy, Mehry El Sobky & Amr Mostafa. Blood, Coagulation & Fibrinolysis, June 2013 (IF: 1.4)
 Plasma Annexin A5, anti-Annexin A5 antibodies and Annexin A5 polymorphism in Egyptian female patients with systemic lupus erythematosus and antiphospholipid syndrome. Aya Nasef, Mona Ibrahim, Nermine Riad, Somaia Mousa. Clinical Laboratory. 2013.130112.
 Plasminogen activator inhibitor-1 4G/5G gene polymorphism in hemodialysis patients with cardiovascular disease. Baheia H. Mostafa, Doha A. Mokhtar, Ahmed M. Badr and Nasser M. Gamal el Din. Egyptian Journal of Haematology 2013, Vol 38, No 1.
 Report on behalf of the International Nosocomial Infection Control Consortium. Victor D. Rosenthal, MD; Rosana Richtmann, MD; Sanjeev Singh, MD; Anucha Apisarnthanarak, MD; Andrzej Ku¨bler, MD; Nguyen Viet-Hung, MD; Fernando M. Ramı´rez-Wong, MD; Jorge H. Portillo-Gallo, MD; Jessica Toscani, MD;9 Achilleas Gikas, MD;10 Lourdes Duen˜as, MD;11 Amani El-Kholy, MD;12 Sameeh Ghazal, MD;13Dale Fisher, MD;14 Zan Mitrev, MD;15 May Osman Gamar-Elanbya, MD;16,17 Souha S. Kanj, MD;18Yolanda Arreza-Galapia, MD;19 Hakan Leblebicioglu, MD;20 Sonˇa Hlinkova´, MD;21,22 Badaruddin A. Memon, MD;23Humberto Guanche- Garcell, MD;24 Vaidotas Gurskis, MD;25 Carlos A´ lvarez-Moreno, MD;26 Amina

27
Barkat, MD;27Nepomuceno Mejı´a, MD;28 Magda Rojas-Bonilla, MD;29 Goran Ristic, MD;30 Lul Raka, MD;31 Cheong Yuet-Meng, MD32. ICHE 2013, vol. 34, no. 6
 Role of CYP2C9, VKORC1 and Calumenin Genotypes in Monitoring Warfarin Therapy: An Egyptian Study. Naguib Zohir1, Reham Afifi1*, Asmaa Ahmed, Zinab Aly, Mehry Elsobekey, Heba Kareem, Rehab Helmy. Macedonian Journal of Medical Sciences. 2013 Dec 15; 6(4): 414-420.
 Source, Pattern and Antibiotic Resistance of Blood Stream Infections in Hematopoietic Stem Cell Transplant Recepients. El Mahallawy H, El Kholy A et al. JENCI-D-13-00013R4 In press, 2013.
 The presence of blaKPC-mediated resistance in Enterobacteriaceae in Cairo University hospitals in Egypt and its correlation with in vitro carbapenem susceptibility. Soheir Fathy Helal; Nevine Gamal Eldin El-Rachidi; Eiman Mohammed AbdulRahman; Dina Mohammed Ahmed Hassan. Journal of Chemotherapy.
 Tissue factor expression on blood monocytes in patients with hepatitis C virus- induced chronic liver disease. N. E. El-Bassiouni & L. O. El Messery & R. A. Zayed &O. B. Metwally & M. Y. Zahran & O. M. Mahmoud &R. A. Ibrahim & A. E. El Bassiouny. Comparative Clinical Pathology, published online May 2013.
 Validation of a Proposed Warfarin Dosing Algorithm Based on the Genetic Make-up of Egyptian Patients.mSherif M.M. Ekladious, Marianne Samir M. Issac, Sahar Abd El- Atty Sharaf, Hazem S. Abou-Youssef. Mol Diagn Ther 2013; 17: 381-390.
 Vascular Endothelial Growth Factor gene polymorphism in Egyptian women with spontaneous recurrent miscarriage, Nelly Abulata, Abeer Nasr & A.M. Hussein, The Journal of the Egyptian Society of Laboratory Medicine, February 2013.
 Viral causes of acute respiratory infection among Egyptian children hospitalized with severe acute asthma exacerbation. Nadia M. Amin, Noussa R. El Basha, Nihal M. El Rifai, Mohamed S. El Baz, Iman H. Draz, Amani A. El Kholy and May M. Sherif. . J Egypt Public Health Assoc 2013, 88:52–56.
6. Training/ Courses/ Workshops Activities
a. Training/ Courses/Workshops Organized by Faculty Members 2013-2014
i. Training Program in Regenerative Medicine (TPRM) a partnership with the University of Toronto in Canada (webcasted course)
 Prof. Dr. Mervat ElAnsary (Director)
 Dr. Mohamed Fateen (Moderator)
 Dr. Riham ElSayed (Moderator)
ii. Workshop: Full Microbiology Lab Automation Solutions and its Benefits in collaboration with BioMerieux International scientific Office, December 2013 (Prof. Dr. Amani El Kholy) iii. Workshop: How to write better multiple choice questions for the medical sciences, in collaboration with Dr Shaadi El Swaify, College of Osteopathic Medicine. Blacksburg, VA, USA (Prof. Dr. Amani El Kholy) iv. Training of doctors on Basics of infection control (Training course) at The Egyptian Medical Syndicate.(From 4- 23 May 2013) (Prof. Dr. Iman Behiry)

28
v. Competency based program of (training of trainers on infection free services) and joining the core team of Misr El Kheir as senior trainer. (27 Jan. 2013) (Prof. Dr. Iman Behiry)
b. Training/ Courses/Workshops Participation by the Faculty
i. Real time PCR workshop, (Part of ESLM Activities) 2013 22 – 24 April, 2013 (Prof. Dr. Sahar Abdel Atty, Prof. Dr. Marianne Samir).
ii. Quality Assurance Workshop, 8-10 March 2011 at AlAzhar Conference Centre (Dr. Dina Mohammed Hasssan)
iii. ESBL's and KPC's to test or not to test.17th April 2012 in the 23rd annual conference of ESLM (Dr. Dina Mohammed Hasssan).
iv. Emerging, zoonotic and infectious diseases that was held in the national research center in collaboration with George Washington University medical center on April 15-18, 2013 (Prof. Dr. Eiman AbdulRahman).
v. Introduction to Biology – The Secret of Life by Eric Lander, MIT University, Online Course (September 2013 – December 2013) (Dr. Riham ElSayed)
vi. Epigenetic Control of Gene Expression, University of Melbourne, passed with distinction, Online course (July 2013 - August 2013) (Dr. Riham ElSayed)
vii. Use of zebrafish as an animal model in congenital kidney diseases: Institute of Genetic Medicine, Newcastle University – UK (June 2013). (Dr. Riham ElSayed)
viii. RAMSES (Stem cell and pediatric cardiology, hand in hand) workshop:
 IPS cells(reprogramming, culture & characterization) 9 MAY 2013
 Magnetic separation techniques 11 MAY 2013
(Prof. Dr. Shereen Shawky, Dr. Safa Meshaal)
7. Conference Activities
a. Conferences Organized by the Faculty
i. The 4th Annual Conference of The Clinical & Chemical Pathology Department, CLINCHEM 28-29 April 2013 (Is Regenerative Medicine a hope or hype?)
-Prof. Dr. Mervat AlAnsary
-Prof. Dr. Hala Gabr
-Prof. Dr. Sahar Abdel Atty
ii. 24th Annual Conference of The Egyptian Society of Laboratory Medicine: A clinician-Friendly Approach 13-15 April, 2013, " Passenger Lymphocyte Syndrome in Solid Organ Transplantation "
-Prof. Dr. Mervat AlAnsary
-Prof. Dr. Soheir Helal
-Prof. Dr. Fatma ElMougy
iii. Co Organized the Annual Conference of the Egyptian Society of Hematology & Research (Prof. Dr. Azza Mostafa)
iv. Co Organized the Annual Conference the Annual Conference for Thalassemia (Prof. Dr. Azza Mostafa)

29
b. Conferences Participation by the Faculty
i. Oral Presentations
 " Dendritic cells in stem cell therapy ", The 13th Annual Conference of The Egyptian Society for Study of Updates in Hepatology and Gastroenterology in Collaboration with The Egyptian Society for study of NAFLD-NASH and its complications, May 30-June 1st, 2013, (Prof. Dr. Mervat AlAnsary).
 Impact of serology and molecular methods on improving the microbiologic diagnosis of infective endocarditis in Egypt, presentation at the 3rd ASMET – The ASM Emerging Technologies Conference, to be held June 25 – 28, 2013, at the Swissotel Grand Efes, in Izmir, Turkey (Prof. Dr. Amani El Kholy).
 Device associated Infections in Adult Intensive Care Units in Public Vs Private Hospitals in Egypt. Amany El Kholy, Iman Beheiry, Mervat enany, May Abd ElFatah, 2nd International Conference on Prevention & Infection Control (ICPIC 2013), Geneva, Switzerland, 25−28 June 2013 (Prof. Dr. Amani El Kholy).
 Prevention of re-use of single-use suction catheter decreased the vap incidence density in a resource-limited adult ICU in Egypt. M. Enany 1, M. Sherif 1, A. A. El Kholy 1, G. L. Saeed 1, E. Sobhy, ICPIC13 (Prof. Dr. Amani El Kholy).
 Fungal endocarditis: early diagnosis aiming at better outcome and predictors of mortality, ISCVID 2013 (Prof. Dr. Amani El Kholy).
 The impact of routine brain ct angiography on treatment decision and mortality in patients with infective endocarditis, ISCVID 2013 (Prof. Dr. Amani El Kholy).
 Neonatal Infections-Related Mortality & Morbidity in Egypt (NIRMM) Conference .The George Washington University and the National Research Centre, Cairo, 2013 (Prof. Dr. Amani El Kholy)
 Blood culture Updated endocarditis diagnosis and management seminar, LRC, 20-11 -2012 (Dr. Dina Mohammed Hasssan).
 TB a Hidden risk. And; Face infection before and after joining work, The 1st Annual conference of occupational health inside hospitals (23rd of March 3013at Cairo University). (Prof. Dr. Iman Behiry)
 HCV infection and prevention, The 28th Annual Congress of Quality and Medicine, from 4-8March 2013 at Tanta University (Prof.Dr. Iman Behiry)
 Introduction to clinical pathology, Your Way To Be a Successful Doctor, The 3rd Annual conference of house officers and fresh Graduates 27- 28February ,2013 At The Egyptian Medical Syndicate(Prof. Dr. Iman Behiry)
 Blood spot versus plasma chitotriosidase: A systematic clinical comparison Egyptian society of laboratory medicine (ESLM) conference (Cairo, April 2013) (Dr. Mohamed Abd Elmoneim)
 CTNS mutations in Egyptian patients with nephropathic cystinosis., Egyptian society for pediatric nephrology and transplantation (ESPNT) conference in partnership with Global kidney academy (GKA) (Cairo, May 2013) (Dr. Mohamed Abd Elmoneim)

30
 Identification and differentiation of the most clinically involved candida species in neonates with candidemia admitted to NICU in Cairo- University Specialized Paediatric Hospital (CUSPH), Microbiological analysis of bacterial and fungal Late onset sepsis in Neonatal Intensive Care Unit Cairo University, Neonatal Infection-Related Mortality & Morbidities Current Status, future perspectives and role of technology
 GWU-NRC Conference - April 15-18, (Prof. Dr. Mona Mohie Eldin)
 DVT from the Laboratory point of view, The Silent Killer; Kasr AlAiny protocol for prophylaxis and treatment, (June 2013 LRC, Cairo Egypt) (Dr. Nelly Abulata)
 “Impact of Circulating Erythrocyte- derived microparticles on Coagulation activation in sickle cell disease”, International Conference on Hematology and Blood Diseases. Raleigh, USA (September 23-25, 2013) (A.Prof. Rania Zayed)
 “Impact of Circulating Erythrocyte- derived microparticles on Coagulation activation in sickle cell disease” 14th International Thalassemia Conference. Cairo, Egypt (8-9/5/ 2013) (A.Prof. Rania Zayed)
 “Comparison between Different Cord Blood Stem Cell Populations in Efficiency of Transdifferentiation into Hepatic Lineage” 1st Annual International Interdisciplinary Conference. Azores, Portugal (24-26/4/ 2013) (A.Prof. Rania Zayed)
 Immun modulatory role of mesenchymal stem cells derived from wharton jelly and adipose tissue, RAMSES Final Conference in collaboration with the Egyptian Working Group of Pediatric Cardiology (Stem cells and pediatric cardiology Hand in Hand) 7-9 May 2013 (Prof.Dr. Shereen Shawky)
 Mesenchymal stem cells from pediatric patients with aplastic anemia: isolation, characterization, adipogenic, and osteogenic differentiation, 4th Annual Scientific Conference of the Clinical and Chemical Pathology Department, CLINCHEM 2013 “Is Regenerative Medicine a hope or a hype?” 28-29th of April 2013 (Prof. Dr. Shereen Shawky)
ii. Poster Presentions
 CYP 17 and Estrogen Receptor α Gene Polymorphisms: Association with Clinico-pathological Parameters in Egyptian Breast Cancer Patients 5th Breast-Gynecological International Cancer Conference (BGICC), 17-18 January 2013, Fairmont Towers Hotel, Cairo, Egypt (Nadida Gohar, Dina El Gayar, Mohammed Shehata, Marianne S.M. Issac, Yasmine Khater, Ezzat Safwat).
 The presence of blaKPC-mediated resistance in Enterobacteriaceae in Cairo University hospitals in Egypt and its correlation with in vitro carbapenem susceptibility. Emerging technology conference in the 3rd ASM, June 25- 28 -2013, Turkey (Dr. Dina Mohammed Hasssan)
 Prevalence of Clostridium difficile among cases of antibiotic associated diarrhea in hospitalized patients in an Egyptian hospital. IMED- February – 2013 (Prof. Dr. Mona Mohie Eldin)

31
 Chitotriosidase enzyme can be used as a screening marker and a therapeutic, monitor for Nephropathic Cystinosis at International pediatric nephrology association (IPNA) conference (Shanghai, China, August 2013). (Dr. Mohamed Abd Elmonem)
 Screening of high risk Egyptian children with suspected inborn errors of metabolism using tandem mass spectrometry: a 5 year report, International congress of inborn errors of metabolism (ICIEM) (Barcelona, Spain, September 2013) (Dr. Mohamed Abd Elmonem)
 The prevalence of inborn errors of metabolism among Egyptian pediatric patients admitted to the intensive care unit using tandem mass spectrometry, International congress of inborn errors of metabolism (ICIEM) (Barcelona, Spain, September 2013) entitled (Dr. Mohamed Abd Elmonem)
 Induction of chitotriosidase in human macrophages by incubation with cystine crystals: Clinical utility in nephropathic cystinosis at American society of nephrology (ASN) conference (Atlanta, USA, November 2013) (Dr. Mohamed Abd Elmonem)
 Restoration of cardiac function in a rat model of isoproterenol induced myocardial injury by transplantation of human mesenchymal stem cells, (ID 341) World Conference on Regenerative Medicine | October 23- 25, 2013 | Leipzig, Germany (Dr. Rabab ElHawary)
 Dihydrorhodamine flow cytometric test in Egyptian patients with symptoms suggestive of chronic granulomatous disease first international primary immunodeficiencies congress , estoril, Portugal, 7-8 Novenmber 2013 (Dr. Rabab ElHawary)
 Detection of CTX-M-type of Extended-Spectrum beta -Lactamases in Klebsiella spp. in Cairo University Hospitals, 3rd Biennial Pathology and Laboratory Medicine Update, 27-28/9/2013, UAE. (Dr. Reham Hamed)
c. Conferences attendance by the Faculty
i. The 4th Annual Conference of The Clinical & Chemical Pathology Department, CLINCHEM 28-29 April 2013(Is Regenerative Medicine a hope or hype?)
ii. The 10th Conference of Egyptian Society of Hematology & Research, 27- 28 November, 2013, " Webcasting from EHA 2013 (Prof. Dr. Mervat AlAnsary)
iii. 5th annual meeting of infection prevention and control in Cairo University Hospitals June 2013 (Prof. Dr. Amani ElKholy, Dr. Dina Mohammed Hasssan)
iv. The 5th Annual Conference of National Hepatology & Tropical Medicine Research Institute ( NHTMRI ), 20-21 November, 2013 (Prof. Dr. Mervat AlAnsary)
v. Ramses Final Conference in collaboration with the Egyptian Working Group of Pediatric Cardiology, 4th International Conference Pediatric

32
Cardiology Department, Cairo University, May 7-9, 2013 (Prof. Dr. Mervat AlAnsary)
vi. 14th International Conference for Thalassemia May 8-9, 2013. (Prof. Dr. Mervat AlAnsary)
vii. The 24th Annual Conference of the Egyptian Society of Laboratory Medicine, 18-20 April 2013
 Prof. Dr. Mervat El Ansary
 Prof. Dr. Shereen Mahmoud
 Prof. Dr. Iman Behiry
 A. Prof. Dr. Maha Gaafar
 A. Prof. Dr. Mervat Khorshied
 A. Prof. Dr. Heba Gouda
 A. Prof. Dr. Rania Zayed
 A. Prof. Dr. Asmaa Abd El-Aal
 Dr. Reham Hamed
viii. European Health Management Association Annual Conference “What healthcare can afford? Better, quicker, lower cost healthcare services” (June 2013, Milano, Italy) (Dr. Nelly Abulata)
ix. Cord blood Inspection and Accreditation Workshop. Monaco, France, (October 23, 2013) (A.Prof. Rania Zayed)
x. First International Primary Immunodeficiencies Congress; Estoril, Portugal, 7th to 8th November 2013 - RAMSES (Dr. Rabab ElHawary)
xi. Final Conference in collaboration with the Egyptian Working Group of Pediatric Cardiology (Stem cells and pediatric cardiology Hand in Hand) 7-9 may 2013 (Dr. Rabab ElHawary)
xii. Ramses closing Conference “Stem Cells and Pediatric Cardiology Hand in Hand“(May 2013, Cairo Egypt) (A.Prof. Rania Zayed , Dr. Rabab ElHawary, Dr. Nelly Abulata, Dr. Riham ElSayed)
xiii. Emerging disease and surveillance (IMED); 13-15 february – 2013, Vienna-Austria (Prof. Dr. Mona Mohie Eldin)
xiv. First International Primary Immunodeficiencies Congress; Estoril, Portugal, 7th to 8th November 2013 (Dr. Safa Meshaal)

34
1. Background Information:
Our Laboratories provide an extensive menu of routine & specialized laboratory tests to the patients who seek care at Kasr Al-Ainy Hospitals.
Lab Divisions
· Hematology Laboratory
· Clinical Immunology & Molecular Diagnostics
· Clinical Microbiology
· Clinical Chemistry
. Blood Bank
2. Total Annual Productivity 5,521,930
0
1000000
2000000
3000000
4000000
5000000
6000000

35
3. Blood Bank Services
a. Blood Bank Profile: The Blood Bank employees approximately 96 people who are involved in Blood Donation, Blood Processing and Hemapheresis.
b. Blood Bank Structure:
i. The Head of the Blood Bank: Prof. Dr. Mervat Al-Ansary
ii. Administrative Director: Dr. Sahar Azab.
iii. The Team includes: 8 Specialists, 1 Financial officers, 26 Technologists & Technicians, 34 Nurses, 17 Administrative Secretaries, 11 Cleaners
c. Blood issued during 2012
Type of Patient
No. Of Units
Inpatient Departments
OR & ER
56,628
Sold Units
2,170
Total no of Units issued
58,798
4. New Tests introduced
 Detection of sepsis bacterial and fungal pathogens by PCR
 Detection of 16 respiratory viral pathogens by multiplex PCR
 Detection of TB and resistance genes by PCR
 Cystine assay in leucocytes for diagnosis of Nephropathic Cystinosis by Tandem Mass Spectrometry.
 Acid sphingomyelinase enzyme assay for diagnosis of Neiman-Pick disease type A/B by spectrofluorometry
37 %
10 %
13 %
11 %
3 %
3 %
18 %
2 %
3 %
% out of the Total annual productivity of 2013
Manial Lab
Japanese Lab
AbouElRish Lab
Internal Medicine Lab
4th Floor Lab
King Fahd Lab
French Lab
Caesium Lab
Maternity Lab

36
 Biotinidase enzyme assay for diagnosis of Biotinidase deficiency by spectrophotometry.
 Galactcerebrosidase enzyme assay for diagnosis of Krabbe disease by spectrofluorometry.
 T cell function assessment, detection of proliferation by flow cytometry in abouelrish children hospital.
 Introducing the extended panel of immune deficiency (Memory and naive cells assessment by flow cytometry) in abouelrish children hospital.
5. New Techniques introduced
 Use of Molecular Biology in diagnosis of viral, bacterial and fungal pathogens
6. New Laboratory at the New ER Hospital
 Opened September 2013.
 Objective: to provide the necessary laboratory service for emergency units in Manial University Hospital, New Emergency Hospital and Women's Hospital. It aims to provide the needed service at the right pace for emergencies.
 Technical and administrative supervision: Department of Clinical and Chemical Pathology
 Location: New Emergency Hospital - Ground Floor
 Characteristics of the place: it has an excellent location as it is part of the New Emergency Hospital and it mediates other hospitals for which it provides the service. Its entrance is through the corridor of the ground floor of the Manial university hospital.
 Working Hours: 24 hours divided into two shifts:
• Morning shift: from 8:00 am to 2:00 pm
• Night shift: from 2:00 pm to 8:00 am
 Laboratory tests available through emergency lab include:
 RBCs Count
 TLC
 Platelet Count
 Differential leukocytic count
 Prothrombin time
 Activated Partial thromboplastin time.
 Fibrinogen
 FDPs

37
 D-Dimer
 Pregnancy test
 Rh blood grouping
 HBsAg, HCV, HIV by rapid test.
 Blood culture
 Biological fluid, tissue specimen, surgical specimens or bronchoalveolar lavage culture
 Urine analysis and examination: strip assay- direct microscopic examination of fresh specimens (centrifugal deposit) - culture from uncentrifuged specimen.
 Bilirubin
 Albumin
 ALT
 AST
 Urea
 Creatinine
 Uric acid
 Blood sugar
 Troponin
 CK-Total
 CK-MB
 CK-MB mass
 LDH
 Calcium
 Electrolytes: Na, K, Mg, Cl
 Amylase
 Blood gases
 β-subunit.
 E2.
 Blood Gases.

7.

38
7. Japanese Laboratory Innovations:
Why did we seek the innovations (Problems);
 Shortage in storage areas.
 Frequent error messages received from instruments.
 Improper temperature control.
 Non convenient laboratory circulation between outpatient clinics and main laboratory.
 Limited small secretarial area inconvenient for IT introduction.
Constructions;
 Compartmentalization of units leading to more effective temperature control through split air conditioning unit.
 Dividing the outpatient sampling unit and creating a new storage area.
 Creating a separate secretarial area with introduction of the IT system.
 Relocation of the autoclaving and media preparation unit of the microbiology section in a separate area instead of inside the main lab.
 Construction of a hematopatology unit.
New instruments;
Hematology;
 Celldyn emerald (gift)
 Centrifuge (donation)
Chemistry;
 Beckman coulter AU480 chemistry analyzer ( reagent deal)
 Gem premier 3000 blood gases analyzer
Immunology;
 Architect ( reagent deal)
2 new air conditioners
New tests introduced;
Hematology
 EMA test for spherocytosis
 Widening of IHC panel: CD117, CD 10, CD 68, CD 138, anti kappa, anti lambda
 Automation of bone marrow biopsy processing, embedding and microtomy which led to decreased turnover time

39
Immunology
 Flowcytometry panel of immunodeficiency; CD3,CD4,CD8,CD19,CD56,HLADR, CD18
 Extended pannel: memory and naïve cells: CD45RO,CD45RA,IgD,CD27.
 Dihydrorhodamine(DHR) assay for neutrophil functions
 T cell function (Proliferation assay by CFSE)
 Antidiphteria ab, antitetanus antibodies
PCR
 Diagnosis of T.B resistant strain by PCR
 Detection of genetic mutations causing cystic fibrosis
 Detection of genetic mutations causing FMF.
Microbiology
 API test
 Helicobacter pylori antigen in stool
 E test for antifungal agents
8. Others introducations
 Starting application of antibiotic policy in cardiothoracic ICU in collaboration with Prof. Dr. Zeinab Salah, Professor of Paediatric and head of Cardiothoracic ICU.- CUSPH- according to guidelines of antibiotic committee- Faculty of medicine – Cairo University
 Introduction of VIVA cards in undergraduate exam
 Preparation of the undergraduate book for 6th year students

41
Department members have long been involved in a variety of community service activities. While many of these are carried out in areas that are not directly related to the mission of the Department, others are regarded as a part of our overall mission. The activities noted below showcase a few of those activities carried out by our Faculty:
1. Awareness & Training sessions in Infection Control all across Kasr Al-Ainy Hospitals.
2. Awareness & Training sessions in Hospital Safety Measures.
3. Annual Laboratory check-ups for employees who are prone to Hospital acquired infection.
4. Laboratory Testing as a part of the almost monthly Medical Convoys by Kasr Al-Ainy Community Service Team to Rural areas.
5. House Officers Career Fair

2013 ClinChem Annual Report

More Related Content

Viewers also liked

Similar to 2013 ClinChem Annual Report

Recently uploaded

2013 ClinChem Annual Report